Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. World most cancers statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 nations. CA: A Most cancers J Clin. 2018;68:394–424.
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal most cancers. Lancet (Lond, Engl). 2019;394:1467–80.
Arneth B. Tumor Microenvironment. Med (Kaunas, Lith). 2019;56:15.
Kelly B, Pearce EL. Amino Property: How Amino Acids Assist Immunity. Cell Metab. 2020;32:154–75.
Zhang H, Wang Y, Li J, Chen H, He X, Zhang H, et al. Biosynthetic vitality value for amino acids decreases in most cancers evolution. Nat Commun. 2018;9:4124.
Leone RD, Zhao L, Englert JM, Solar IM, Oh MH, Solar IH, et al. Glutamine blockade induces divergent metabolic applications to beat tumor immune evasion. Sci (N. Y, NY). 2019;366:1013–21.
Muthusamy T, Cordes T, Handzlik MK, You L, Lim EW, Gengatharan J, et al. Serine restriction alters sphingolipid range to constrain tumour development. Nature. 2020;586:790–5.
Liu D, Liang CH, Huang B, Zhuang X, Cui W, Yang L, et al. Tryptophan Metabolism Acts as a New Anti-Ferroptotic Pathway to Mediate Tumor Progress. Adv Sci (Weinh). 2023;10:e2204006.
van Acker BA, Hulsewé KW, Wagenmakers AJ, von Meyenfeldt MF, Soeters PB. Response of glutamine metabolism to glutamine-supplemented parenteral diet. Am J Clin Nutr. 2000;72:790–5.
Oudemans-van Straaten HM, van Zanten AR. Glutamine supplementation within the critically in poor health: pal or foe? Crit Care. 2014;18:143.
Oh MH, Solar IH, Zhao L, Leone RD, Solar IM, Xu W, et al. Focusing on glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells. J Clin Make investments. 2020;130:3865–84.
Yu W, Huang J, Dong Q, Li W, Jiang L, Zhang Q, et al. Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Impact on Colorectal Most cancers Cells. Entrance Pharmacol. 2022;13:871392.
Smart DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and results in glutamine habit. Proc Natl Acad Sci USA. 2008;105:18782–7.
Liu HY, Zhang HS, Liu MY, Li HM, Wang XY, Wang M. GLS1 depletion inhibited colorectal most cancers proliferation and migration through redox/Nrf2/autophagy-dependent pathway. Arch Biochem Biophys. 2021;708:108964.
Chen P, Liu XQ, Lin X, Gao LY, Zhang S, Huang X. Focusing on YTHDF1 successfully re-sensitizes cisplatin-resistant colon most cancers cells by modulating GLS-mediated glutamine metabolism. Mol Ther Oncolyt. 2021;20:228–39.
Toda Okay, Nishikawa G, Iwamoto M, Itatani Y, Takahashi R, Sakai Y, et al. Scientific Function of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Most cancers. Int J Mol Sci. 2017;18:1632.
Chen H, Yao J, Bao R, Dong Y, Zhang T, Du Y, et al. Cross-talk of 4 varieties of RNA modification writers defines tumor microenvironment and pharmacogenomic panorama in colorectal most cancers. Mol most cancers. 2021;20:29.
Stefani C, Miricescu D, Stanescu S II, Nica RI, Greabu M, Totan AR, et al. Progress Elements, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Most cancers Pathogenesis: The place Are We Now? Int J Mol Sci. 2021;22:10260.
Vodnala SK, Eil R, Kishton RJ, Sukumar M, Yamamoto TN, Ha NH, et al. T cell stemness and dysfunction in tumors are triggered by a typical mechanism. Sci (N. Y, NY). 2019;363:eaau0135.
Kumar A, Xu J, Brady S, Gao H, Yu D, Reuben J, et al. Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells. PLoS One. 2010;5:e13390.
Bertero T, Oldham WM, Grasset EM, Bourget I, Boulter E, Pisano S, et al. Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Maintain Tumor Progress and Malignancy. Cell Metab. 2019;29:124–40.e10.
Fernstrom JD. Results and unwanted side effects related to the non-nutritional use of tryptophan by people. J Nutr. 2012;142:2236s–44s.
Fernstrom MH, Fernstrom JD. Mind tryptophan concentrations and serotonin synthesis stay conscious of meals consumption after the ingestion of sequential meals. Am J Clin Nutr. 1995;61:312–9.
Solar XZ, Zhao DY, Zhou YC, Wang QQ, Qin G, Yao SK. Alteration of fecal tryptophan metabolism correlates with shifted microbiota and could also be concerned in pathogenesis of colorectal most cancers. World J Gastroenterol. 2020;26:7173–90.
Venkateswaran N, Lafita-Navarro MC, Hao YH, Kilgore JA, Perez-Castro L, Braverman J, et al. MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon most cancers. Genes Dev. 2019;33:1236–51.
Zhang X, Liu X, Zhou W, Du Q, Yang M, Ding Y, et al. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Related Colon Most cancers through Inhibiting Immune Tolerance. Cell Mol Gastroenterol Hepatol. 2021;12:1179–99.
Lee R, Li J, Li J, Wu CJ, Jiang S, Hsu WH, et al. Artificial Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Most cancers. Most cancers Discov. 2022;12:1702–17.
Wang D, Wang X, Si M, Yang J, Solar S, Wu H. et al. Corrigendum to “Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal most cancers by enhancing M2 polarization of macrophages” Most cancers Lett. 474 (2020) 36–52). Most cancers Lett. 2022;525:200–2.
Ay, Demirkol EN, Hakan MT, Horozoğlu C, Arıkan S, Doğan MB, et al. Investigation of potential associations between tryptophan/kynurenine standing and FOXP3 expression in colorectal most cancers. Scand J Clin Lab Investig. 2022;82:185–91.
Deng B, Yang B, Chen J, Wang S, Zhang W, Guo Y, et al. Gallic acid induces T-helper-1-like T(reg) cells and strengthens immune checkpoint blockade efficacy. J Immunother Most cancers. 2022;10:e004037.
Scott AC, Dündar F, Zumbo P, Chandran SS, Klebanoff CA, Shakiba M, et al. TOX is a important regulator of tumour-specific T cell differentiation. Nature. 2019;571:270–4.
Chen B, Alvarado DM, Iticovici M, Kau NS, Park H, Parikh PJ, et al. Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Goal in Colorectal Most cancers. Most cancers Immunol Res. 2020;8:451–64.
De Simone M, Arrigoni A, Rossetti G, Gruarin P, Ranzani V, Politano C, et al. Transcriptional Panorama of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells. Immunity. 2016;45:1135–47.
Soares J, Raimundo L, Pereira NA, Monteiro Â, Gomes S, Bessa C, et al. Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule. Oncotarget. 2016;7:4326–43.
Barcherini V, Almeida J, Lopes EA, Wang M, Magalhães ESD, Mori M, et al. Efficiency and Selectivity Optimization of Tryptophanol-Derived Oxazoloisoindolinones: Novel p53 Activators in Human Colorectal Most cancers. ChemMedChem. 2021;16:250–8.
Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, et al. Restoration of p53 operate results in tumour regression in vivo. Nature. 2007;445:661–5.
Warburg O. On the origin of most cancers cells. Sci (N. Y, NY). 1956;123:309–14.
Chen H, Zheng X, Zong X, Li Z, Li N, Hur J, et al. Metabolic syndrome, metabolic comorbid situations and threat of early-onset colorectal most cancers. Intestine. 2021;70:1147–54.
Hussain A, Qazi AK, Mupparapu N, Guru SK, Kumar A, Sharma PR, et al. Modulation of glycolysis and lipogenesis by novel PI3K selective molecule represses tumor angiogenesis and reduces colorectal most cancers development. Most cancers Lett. 2016;374:250–60.
Wu F, Gao P, Wu W, Wang Z, Yang J, Di J, et al. STK25-induced inhibition of cardio glycolysis through GOLPH3-mTOR pathway suppresses cell proliferation in colorectal most cancers. J Exp Clin most cancers Res: Cr. 2018;37:144.
Peng Okay, Zhuo M, Li M, Chen Q, Mo P, Yu C. Histone demethylase JMJD2D prompts HIF1 signaling pathway through a number of mechanisms to advertise colorectal most cancers glycolysis and development. Oncogene. 2020;39:7076–91.
Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, et al. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal most cancers. J Exp Clin most cancers Res: Cr. 2022;41:15.
Li C, Chen Q, Zhou Y, Niu Y, Wang X, Li X, et al. S100A2 promotes glycolysis and proliferation through GLUT1 regulation in colorectal most cancers. FASEB J. 2020;34:13333–44.
Ji L, Shen W, Zhang F, Qian J, Jiang J, Weng L, et al. Worenine reverses the Warburg impact and inhibits colon most cancers cell development by negatively regulating HIF-1α. Cell Mol Biol Lett. 2021;26:19.
Gu M, Zhou X, Sohn JH, Zhu L, Jie Z, Yang JY, et al. NF-κB-inducing kinase maintains T cell metabolic health in antitumor immunity. Nat Immunol. 2021;22:193–204.
Shi Q, Shen Q, Liu Y, Shi Y, Huang W, Wang X, et al. Elevated glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to advertise most cancers metastasis and chemoresistance. Most cancers cell. 2022;40:1207–22.e10.
Zhao S, Mi Y, Guan B, Zheng B, Wei P, Gu Y, et al. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to advertise liver metastasis of colorectal most cancers. J Hematol Oncol. 2020;13:156.
Bohn T, Rapp S, Luther N, Klein M, Bruehl TJ, Kojima N, et al. Tumor immunoevasion through acidosis-dependent induction of regulatory tumor-associated macrophages. Nat Immunol. 2018;19:1319–29.
Lu Y, Li Y, Liu Q, Tian N, Du P, Zhu F, et al. MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identification and Perform in Colorectal Most cancers Microenvironment. Gastroenterology. 2021;161:575–91.e16.
Wei J, Lengthy L, Yang Okay, Man C, Shrestha S, Chen Z, et al. Autophagy enforces useful integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat Immunol. 2016;17:277–85.
Weng ML, Chen WK, Chen XY, Lu H, Solar ZR, Yu Q, et al. Fasting inhibits cardio glycolysis and proliferation in colorectal most cancers through the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression. Nat Commun. 2020;11:1869.
Zhu D, Jiang Y, Cao H, Yang J, Shu Y, Feng H, et al. Lactate: A regulator of immune microenvironment and a scientific prognosis indicator in colorectal most cancers. Entrance Immunol. 2022;13:876195.
Qian J, Gong ZC, Zhang YN, Wu HH, Zhao J, Wang LT, et al. Lactic acid promotes metastatic area of interest formation in bone metastasis of colorectal most cancers. Cell Commun Sign: Ccs. 2021;19:9.
Zhang Y, Li J, Wang B, Chen T, Chen Y, Ma W. LDH-A negatively regulates dMMR in colorectal most cancers. Most cancers Sci. 2021;112:3050–63.
Hu L, Huang S, Chen G, Li B, Li T, Lin M, et al. Nanodrugs Incorporating LDHA siRNA Inhibit M2-like Polarization of TAMs and Amplify Autophagy to Help Oxaliplatin Chemotherapy in opposition to Colorectal Most cancers. ACS Appl Mater Interfaces. 2022;14:31625–33.
Xu Okay, Zhan Y, Yuan Z, Qiu Y, Wang H, Fan G, et al. Hypoxia Induces Drug Resistance in Colorectal Most cancers via the HIF-1α/miR-338-5p/IL-6 Suggestions Loop. Mol Ther : J Am Soc Gene Ther. 2019;27:1810–24.
Zhang W, Tong D, Liu F, Li D, Li J, Cheng X, et al. RPS7 inhibits colorectal most cancers development through lowering HIF-1α-mediated glycolysis. Oncotarget. 2016;7:5800–14.
Li N, Kang Y, Wang L, Huff S, Tang R, Hui H, et al. ALKBH5 regulates anti-PD-1 remedy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci USA. 2020;117:20159–70.
Yang J, Wei H, Zhou Y, Szeto CH, Li C, Lin Y, et al. Excessive-Fats Food regimen Promotes Colorectal Tumorigenesis By Modulating Intestine Microbiota and Metabolites. Gastroenterology. 2022;162:135–49.e2.
Ringel AE, Drijvers JM, Baker GJ, Catozzi A, García-Cañaveras JC, Gassaway BM, et al. Weight problems Shapes Metabolism within the Tumor Microenvironment to Suppress Anti-Tumor Immunity. Cell. 2020;183:1848–66.e26.
Cotte AK, Aires V, Fredon M, Limagne E, Derangère V, Thibaudin M, et al. Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet manufacturing helps colorectal most cancers chemoresistance. Nat Commun. 2018;9:322.
Liu R, Lee JH, Li J, Yu R, Tan L, Xia Y, et al. Choline kinase alpha 2 acts as a protein kinase to advertise lipolysis of lipid droplets. Mol cell. 2021;81:2722–35.e9.
Wu H, Han Y, Rodriguez Sillke Y, Deng H, Siddiqui S, Treese C, et al. Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages. EMBO Mol Med. 2019;11:e10698.
Xia D, Wang D, Kim SH, Katoh H, DuBois RN. Prostaglandin E2 promotes intestinal tumor development through DNA methylation. Nat Med. 2012;18:224–6.
O’Callaghan G, Kelly J, Shanahan F, Houston A. Prostaglandin E2 stimulates Fas ligand expression through the EP1 receptor in colon most cancers cells. Br J most cancers. 2008;99:502–12.
Paschall AV, Yang D, Lu C, Choi JH, Li X, Liu F, et al. H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance. J Immunol (Baltim, Md : 1950). 2015;195:1868–82.
Chang J, Vacher J, Yao B, Fan X, Zhang B, Harris RC, et al. Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis. Oncotarget. 2015;6:33500–11.
Lin D, Zhang H, Liu R, Deng T, Ning T, Bai M, et al. iRGD-modified exosomes successfully ship CPT1A siRNA to colon most cancers cells, reversing oxaliplatin resistance by regulating fatty acid oxidation. Mol Oncol. 2021;15:3430–46.
Hossain F, Al-Khami AA, Wyczechowska D, Hernandez C, Zheng L, Reiss Okay, et al. Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Capabilities of Myeloid-Derived Suppressor Cells and Enhances Most cancers Therapies. Most cancers Immunol Res. 2015;3:1236–47.
van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, Amiel E, et al. Mitochondrial respiratory capability is a important regulator of CD8+ T cell reminiscence growth. Immunity. 2012;36:68–78.
Bai Y, Zhou X, Li N, Zhao J, Ye H, Zhang S, et al. In Vitro Fermentation Traits and Fiber-Degrading Enzyme Kinetics of Cellulose, Arabinoxylan, β-Glucan and Glucomannan by Pig Fecal Microbiota. Microorganisms. 2021;9:1071.
Alula KM, Dowdell AS, LeBere B, Lee JS, Levens CL, Kuhn KA, et al. Interaction of intestine microbiota and host epithelial mitochondrial dysfunction is important for the event of spontaneous intestinal irritation in mice. Microbiome. 2023;11:256.
Nøhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology. 2013;154:3552–64.
Sina C, Gavrilova O, Förster M, Until A, Derer S, Hildebrand F, et al. G protein-coupled receptor 43 is important for neutrophil recruitment throughout intestinal irritation. J Immunol (Baltim, Md : 1950). 2009;183:7514–22.
Düvel Okay, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, et al. Activation of a metabolic gene regulatory community downstream of mTOR advanced 1. Mol cell. 2010;39:171–83.
Wen YA, Xiong X, Zaytseva YY, Napier DL, Vallee E, Li AT, et al. Downregulation of SREBP inhibits tumor development and initiation by altering mobile metabolism in colon most cancers. Cell loss of life Dis. 2018;9:265.
Du Q, Wang Q, Fan H, Wang J, Liu X, Wang H, et al. Dietary ldl cholesterol promotes AOM-induced colorectal most cancers via activating the NLRP3 inflammasome. Biochemical Pharmacol. 2016;105:42–54.
Liu C, Yao Z, Wang J, Zhang W, Yang Y, Zhang Y, et al. Macrophage-derived CCL5 facilitates immune escape of colorectal most cancers cells through the p65/STAT3-CSN5-PD-L1 pathway. Cell loss of life Differ. 2020;27:1765–81.
Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, et al. Ldl cholesterol Induces CD8(+) T Cell Exhaustion within the Tumor Microenvironment. Cell Metab. 2019;30:143–56.e5.
Raufman JP, Shant J, Guo CY, Roy S, Cheng Okay. Deoxycholyltaurine rescues human colon most cancers cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling. J Cell Physiol. 2008;215:538–49.
Lee HY, Crawley S, Hokari R, Kwon S, Kim YS. Bile acid regulates MUC2 transcription in colon most cancers cells through constructive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkappaB/NF-kappaB and p38/MSK1/CREB pathways and detrimental JNK/c-Jun/AP-1 pathway. Int J Oncol. 2010;36:941–53.
Van den Eynde M, Mlecnik B, Bindea G, Fredriksen T, Church SE, Lafontaine L, et al. The Hyperlink between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Most cancers Sufferers. Most cancers cell. 2018;34:1012–26.e3.
Qiao D, Gaitonde SV, Qi W, Martinez JD. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation. Carcinogenesis. 2001;22:957–64.
Keerthivasan S, Aghajani Okay, Dose M, Molinero L, Khan MW, Venkateswaran V, et al. β-Catenin promotes colitis and colon most cancers via imprinting of proinflammatory properties in T cells. Sci Transl Med. 2014;6:225ra28.
Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell. 2012;150:780–91.
Zhang D, Shi R, Xiang W, Kang X, Tang B, Li C, et al. The Agpat4/LPA axis in colorectal most cancers cells regulates antitumor responses through p38/p65 signaling in macrophages. Sign Transduct Goal Ther. 2020;5:24.
Wang Z, Little N, Chen J, Lambesis KT, Le KT, Han W, et al. Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for secure and synergistic most cancers immunochemotherapy. Nat Nanotechnol. 2021;16:1130–40.
